Skip to main content
Equibles
KRMD logo

KRMD · KORU Medical Systems, Inc. · Webcasts, Transcripts & Audio

Track KRMD — free

Use KRMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 -0.01 (-0.32%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$146.36M
Shares
46.17M
Volume · Oct 28 10.83K Avg daily vol (3M) 240.26K

KORU Medical Systems, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for KORU Medical Systems, Inc. (KRMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-10
KORU Medical Systems, Inc. (KRMD) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-08-12
KORU Medical Systems, Inc. (KRMD) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
Confident tone International expansion (pre-filled syringe markets) Secondary immunodeficiency (SID) opportunity Domestic core IG growth and market share
Revenue
$12.05M
▲ 18.2% YoY
Diluted EPS
$0.01
Gross margin
65.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
Confident tone SID (secondary immunodeficiency) opportunity Non-IG pipeline and drug expansion Domestic core business growth
Revenue
$11.76M
▲ 22.1% YoY
Diluted EPS
$-0.02
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
Confident tone Revenue growth and full year results RYSTIGGO and infusion clinic channel 2026 guidance and outlook
Revenue
$10.90M*
▲ 23.3% YoY
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
Confident tone US SCIG Core Business International Expansion and Prefilled Syringes Oncology Infusion Opportunity
Revenue
$10.40M
▲ 27.2% YoY
Diluted EPS
$0.02
▼ 33.3% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
Confident tone Guidance and Forward Outlook Core Domestic Business New Drug Pipeline and Label Expansions
Revenue
$10.19M
▲ 20.9% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript
Confident tone International expansion Tariffs and gross margin 510(k) submissions and new drugs on label pipeline
Revenue
$9.64M
▲ 17.5% YoY
Diluted EPS
$-0.03
▼ 175% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript
Confident tone International Expansion Domestic Core Business and SCIg Market Tariffs and Supply Chain
Revenue
$8.84M*
▲ 23% YoY
Gross margin
62.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
Confident tone Novel Therapies Pipeline Domestic Core SCIg Business International Expansion
Revenue
$8.18M
▲ 16.8% YoY
Diluted EPS
$0.03
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
KORU Medical Systems, Inc. (KRMD) Q2 2024 Earnings Call Transcript
Confident tone International Expansion Novel Therapies / Pipeline Collaborations Core Domestic SCIg Business Growth
Revenue
$8.43M
▲ 21.5% YoY
Diluted EPS
$0.02
Gross margin
65.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript
Confident tone Novel Therapies pipeline and collaborations International expansion and BSI/MDR regulatory progress 2024 guidance reaffirmation
Revenue
$8.20M
▲ 10.9% YoY
Diluted EPS
$0.04
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-13
KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript
Positive tone Novel Therapies Pipeline International Expansion Domestic SCIg Core Business
Revenue
$7.19M*
▼ 2.2% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
KORU Medical Systems, Inc. (KRMD) Q3 2023 Earnings Call Transcript
Revenue
$7.00M
▼ 9.8% YoY
Diluted EPS
$-0.03
Gross margin
62.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
KORU Medical Systems, Inc. (KRMD) Q2 2023 Earnings Call Transcript
Revenue
$6.94M
▲ 5.9% YoY
Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
KORU Medical Systems, Inc. (KRMD) Q1 2023 Earnings Call Transcript
Revenue
$7.39M
▲ 18.4% YoY
Diluted EPS
$-0.05
Gross margin
56.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-08
KORU Medical Systems, Inc. (KRMD) Q4 2022 Earnings Call Transcript
Revenue
$7.34M*
▲ 13.2% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
KORU Medical Systems, Inc. (KRMD) Q3 2022 Earnings Call Transcript
Revenue
$7.76M
▲ 28.5% YoY
Diluted EPS
$-0.03
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
KORU Medical Systems, Inc. (KRMD) Q2 2022 Earnings Call Transcript
Revenue
$6.55M
▲ 18.4% YoY
Diluted EPS
$-0.07
Gross margin
51.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
KORU Medical Systems, Inc. (KRMD) Q1 2022 Earnings Call Transcript
Revenue
$6.24M
▲ 15% YoY
Diluted EPS
$-0.06
Gross margin
58.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-02
KORU Medical Systems, Inc. (KRMD) Q4 2021 Earnings Call Transcript
Revenue
$6.49M*
▲ 60% YoY
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
KORU Medical Systems, Inc. (KRMD) Q3 2021 Earnings Call Transcript
Revenue
$6.04M
▼ 0.7% YoY
Diluted EPS
$-0.02
▼ 300% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-11
KORU Medical Systems, Inc. (KRMD) Q2 2021 Earnings Call Transcript
Revenue
$5.53M
▼ 28.3% YoY
Diluted EPS
$-0.03
Gross margin
58.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
KORU Medical Systems, Inc. (KRMD) Q1 2021 Earnings Call Transcript
Revenue
$5.43M
▼ 14.2% YoY
Diluted EPS
$-0.03
▼ 400% YoY
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-26
KORU Medical Systems, Inc. (KRMD) Q4 2020 Earnings Call Transcript
Revenue
$4.06M*
▼ 34.8% YoY
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
KORU Medical Systems, Inc. (KRMD) Q3 2020 Earnings Call Transcript
Revenue
$6.08M
▼ 8.1% YoY
Diluted EPS
$0.01
▼ 50% YoY
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
KORU Medical Systems, Inc. (KRMD) Q2 2020 Earnings Call Transcript
Revenue
$7.71M
▲ 44.1% YoY
Diluted EPS
$-0.03
Gross margin
63.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
KORU Medical Systems, Inc. (KRMD) Q1 2020 Earnings Call Transcript
Revenue
$6.33M
▲ 27.3% YoY
Diluted EPS
$0.01
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
KORU Medical Systems, Inc. (KRMD) Q4 2019 Earnings Call
Revenue
$6.22M*
▲ 45.7% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–29 of 29 webcasts
Key facts CIK 704440 CUSIP 759910102 13F (30d) 6 filings 6 filers Visit website Investor relations